The present report describes the first reported case of microscopic pulmonary tumour embolism (MPTE) from thymic carcinoma. The carcinoma was discovered during an autopsy in a 55-year-old man who had undergone surgery for a pilonidal sinus two weeks before presentation. Pulmonary thromboembolism was suspected. This case was unusual because MPTE has never before been associated with thymic carcinoma, MPTE was the first clinical indication of an occult malignancy, and the clinical presentation was that of sudden onset of dyspnea associated with acute cor pulmonale. The cause of death was determined to be hypoxia secondary to extrinsic compression of the right pulmonary artery and extensive tumour emboli in the small arteries, arterioles and venules of the pulmonary parenchyma. A review of the clinical presentation and diagnosis of MPTE is included. Ce cas était inhabituel car l'EMTP constituait le première indication clinique de malignité occulte, et la présentation clinique en était une de dyspnée d'apparition soudaine associée à un cor pulmonare aigu. La cause du décès a été déterminée comme une hypoxie secondaire à une compression extrinsèque de l'artère pulmonaire droite et à une embolie tumorale éten-due dans les petites artères, les artérioles et les vénules du parenchyme pulmonaire. L'analyse de la présentation clinique et du diagnostic d'EMTP est incluse.
M icroscopic pulmonary tumour embolism (MPTE) is an underdiagnosed pathology that is a frequent cause of morbidity and mortality in patients with cancer (1) (2) (3) . Most patients with MPTE have an established and often metastatic malignancy, the most common of which include stomach, breast, lung, prostate and pancreatic cancer, hepatocellular carcinoma, and choriocarcinoma (4) . MPTE is rarely the first clinical sign of cancer. The most common presenting complaint of patients with MPTE is subacute dyspnea (1) (2) (3) (4) (5) .
In the present paper, we describe a patient who had a primary thymic carcinoma with MPTE. This case is unusual for three reasons. First and most important, to our knowledge, it is the first reported case of MPTE associated with thymic carcinoma. Second, MPTE was the first clinical sign of the malignancy. Finally, the patient presented with acute dyspnea associated with acute cor pulmonale.
CASE PRESENTATION
A 55-year-old, previously healthy man presented with a four-day history of progressive shortness of breath that began suddenly. He had a new cough productive of brown sputum. He denied any chest pain. He had a smoking history of 60 pack-years, but nothing to suggest chronic obstructive pulmonary disease. He had undergone surgery for a pilonidal sinus two weeks previously and had thus been relatively immobile. Pulmonary embolism was considered to be highly possibile.
On physical examination, the patient's blood pressure was 93/70 mmHg, his pulse was 140 beats/min, his respiratory rate was 30 breaths/min and his temperature was 37.4°C. His oxygen saturation on room air was 82%. He had quiet breath sounds and inspiratory crackles bilaterally, and his heart sounds were normal but decreased. His jugular venous pressure was slightly elevated, and his legs and feet were poorly perfused, with weak peripheral pulses. He had no peripheral edema or calf tenderness.
A chest roentgenogram demonstrated patchy consolidation and pleural effusion of the right lung, cardiomegaly, and mediastinal and left hilar lymphadenopathy. An electrocardiogram (ECG) showed tachycardia, as well as new features compared with an ECG performed two weeks previously, including a right bundle branch block, and symmetrical inversion of T waves in leads V1 to V4, II, III and aVF. His white blood cell count was elevated at 12×10 9 /L, his platelet count was 129×10 9 /L, his potassium level was low at 3.1 mmol/L, and his blood urea nitrogen and creatinine levels were elevated at 11.7 mmol/L and 172 µmol/L, respectively.
High flow oxygen therapy, intravenous fluids and heparin infusion were commenced; however, despite an initial rise to 96%, his oxygen saturation had dropped to 86% by the next morning. An analysis of his arterial blood gases showed a pH of 7.48, a partial pressure of oxygen of 47 mmHg, a partial pressure of carbon dioxide of 26 mmHg and a bicarbonate concentration of 17 mEq/L. A pulmonary nuclear perfusion scan did not demonstrate discrete segmental or subsegmental perfusion defects, making the probability of pulmonary thromboembolic disease low (the patient was unable to tolerate the ventilation study). A chest computer tomography scan ( Figure 1 ) using a dedicated pulmonary embolism protocol demonstrated multiple enlarged lymph nodes in the anterior mediastium, aortic pulmonary window, and pretracheal, paratracheal and subcarinal regions, as well as increased soft tissue adjacent to the right main stem bronchus and right lower lobe bronchus. These findings appeared to be representative of a lymphoma or metastatic disease. The chest computer tomography scan also showed compression of the right pulmonary artery at the level of the main stem bronchus, most likely because of an extrinsic mass. A pulmonary angiogram was not completed because there was a very high likelihood of malignancy.
The patient's oxygen saturation continued to drop, and the decision was made to intubate and ventilate him. However, he continued to deteriorate and died two days after his admission.
An autopsy revealed an 11 cm ×7 cm ×5 cm irregular, lobular mass in the anterior mediastinum, surrounding the trachea, right main bronchus, upper part of the thoracic aorta, the right pulmonary artery, the aortic arch, a portion of the superior vena cava and the middle esophagus. There was a second 15 cm × 15 cm × 5 cm lobular para-aortic mass just above and around the bifurcation of the common iliac arteries. There were no masses in the lungs, gastrointestinal tract, liver, pancreas, prostate, kidney or testicles (gross and microscopic). The right ventricle was dilated without hypertrophy.
Microscopic examination of the mediastinal mass showed a lobulated lesion composed of discohesive cells with enlarged, vesicular nuclei and prominent nucleoli ( Figure 2 ). Numerous tumour giant cells and mitotic figures were present. Extensive areas of tumour necrosis and lym- Immunohistochemical analysis showed that the neoplastic cells were positive for high molecular weight keratin (HMWK), an epithelial cell marker, and CD-5, a type of receptor molecule that signals cell growth in T cells. These findings support a diagnosis of thymic carcinoma, because the lesional cells from thymic carcinoma were positive for HMWK and CD-5 (6). Neoplastic cells in most thymomas and carcinomas of nonthymic origins are negative for coexpression of HMWK and CD-5. With additional immunohistochemical analysis, the neoplastic cells were found to be negative for epithelial membrane antigen, smooth muscle antigen, S-100, CD-45, vimentin, placental alkaline phosphatase and alpha-fetoprotein. These findings rule out the diagnosis of a metastatic melanoma, lymphoma, sarcoma or metastatic testicular tumour, and support the diagnosis of undifferentiated (anaplastic) thymic carcinoma with metastasis to mediastinal and para-aortic lymph nodes.
Sections from the lungs showed multiple microscopic tumour emboli distributed diffusely within pulmonary arteries, arterioles, pulmonary septal capillaries, venules and veins, with variable occlusion of the vascular lumens ( Figure 3 ). Numerous lymphatic vessels were also filled by tumour emboli.
The cause of death was determined to be hypoxia secondary to extrinsic compression of the right pulmonary artery and numerous tumour emboli in vessels of the pulmonary parenchyma.
DISCUSSION
Pulmonary embolism can develop from either detached thrombi or tumours in patients with cancer. Pulmonary tumour emboli may be large or microscopic. MPTE, though a frequent cause of morbidity and mortality in patients with cancer, is not frequently diagnosed antemortem (7) . Based on autopsy studies, the incidence of MPTE in patients with solid neoplasms ranges from 2% to 26% and is the cause of death in up to 14 % of these cases (2, 7, 8) . MPTE has been reported in patients with breast, lung, prostate, pancreatic, gastric, gallbladder, bladder, colorectal, skin, cervical and uterine cancer, hepatocellular carcinoma, and choriocarcinoma (4, 5) . The present case is, therefore, unique because, to our knowledge, it is the first reported thymic carcinoma associated with MPTE.
Thymic carcinoma is a rare tumour associated with a poor prognosis. The most common presenting symptoms of thymic carcinoma -chest pain, cough and dyspnea -are secondary to tumour invasion or compression of the airways and adjacent lung, and are not due to MPTE as presently described. In an analysis of 19 clinicopathological studies of thymic carcinoma (9), 52% of patients developed metastases. Although metastases to the lung parenchyma are not unusual in thymic carcinoma, microscopic tumour embolism in the pulmonary vessels from thymic carcinoma has never before been reported.
MPTE is rarely the first clinical sign of malignancy. It usually occurs in patients with an established and frequently metastatic tumour (4) . A few cases in the literature to date report MPTE as the first indication of cancer (4, 10, 11) . These malignancies were of the liver, pancreas, stomach, ovaries and breast.
The most common presenting symptom of patients with MPTE is subacute cor pulmonale associated with progressive dyspnea ranging from weeks to months in duration before diagnosis or death (1,3,4,8) . There are few reports of patients presenting with acute cor pulmonale who have sudden onset of dyspnea and rapid development of respiratory failure (12) (13) (14) . In the present case, the patient's shortness of breath came on suddenly and lasted for four days before admission. Once in the hospital, he rapidly deteriorated, required mechanical ventilation and died within two days. Thus, his cumulative symptom duration was only six days. Classically, the physical examination of patients with MPTE reveals signs of pulmonary hypertension: tachycardia, tachypnea, normal lung auscultation, increased jugular venous pressure and a loud pulmonic second heart sound. Usually, an ECG shows nonspecific changes, with a sinus tachycardia (7) . A right ventricular strain pattern was noted in our patient, likely due to the increased right ventricular systolic pressure secondary to pulmonary hypertension. Analysis of blood gases typically reveals hypoxemia (7) . The tumour cell embolization of pulmonary circulation causes unrelenting respiratory distress out of proportion to the physical findings in the heart and lungs.
The histological changes of the vascular bed are primarily intra-arterial; therefore, the roentogenographic findings are either absent or meager (2) . Normal-appearing lungs on a chest radiograph in association with severe respiratory symptoms is typical of MPTE. There is usually no marked pulmonary hypertension or cardiopulmonary functional derangements until 60% to 80% of the pulmonary arterial bed has been occluded by the tumour emboli.
Ventilation-perfusion scans may demonstrate subsegmental perfusion defects without ventilatory defects (15) . Pulmonary angiography usually shows no evidence of emboli, but may demonstrate slowed filling, tortuosity or pruning of small peripheral vessels (16) .
Any malignancy may be a source of pulmonary tumour emboli. On the other hand, microscopic pulmonary emboli may result from thrombophlebitis in the lower extremities, especially in patients with prolonged bed rest. The determination of the origin of pulmonary emboli has therapeutic implications, because anticoagulation is indicated in thrombotic emboli but not in tumour emboli. Furthermore, with advances in chemotherapy, MPTE may be treatable if diagnosed correctly antemortem (7) .
To confirm the diagnosis, tissue must be obtained by open lung biopsy or transbronchial biopsy. A recently described, less invasive procedure using pulmonary microvascular cytology of blood samples obtained from a Swan Ganz catheter may be useful in the detection of tumour cell embolization (17) . 
